Identification of differentially expressed circulating exosomal lncRNAs in IgA nephropathy patients

BMC Immunol. 2020 Mar 31;21(1):16. doi: 10.1186/s12865-020-00344-1.

Abstract

Background: Although immunoglobulin A nephropathy (IgAN) is one of the foremost primary glomerular disease, treatment of IgAN is still in infancy. Non-invasive biomarkers are urgently needed for IgAN diagnosis. We investigate the difference in expression profiles of exosomal long non-coding-RNAs (lncRNAs) in plasma from IgAN patients compared with their healthy first-degree relatives, which may reveal novel non-invasive IgAN biomarkers.

Methods: We isolated exosomes from the plasma of both IgAN patients and their healthy first-degree relatives. High-throughput RNA sequencing and real-time quantitative polymerase chain reaction (qRT-PCR) was used to validate lncRNA expression profiles. Pathway enrichment analysis was used to predict their nearest protein-coding genes.

Results: lncRNA-G21551 was significantly down-regulated in IgAN patients. Interestingly, the nearest protein-coding gene of lncRNA-G21551 was found to be encoding the low affinity receptor of the Fc segment of immunoglobulin G (FCGR3B).

Conclusions: Exosomal lncRNA-G21551, with FCGR3B as the nearest protein-coding gene, was down-regulated in IgAN patients, indicating its potential to serve as a non-invasive biomarker for IgAN.

Keywords: Biomarker; Exosome; High-throughput sequencing; IgA nephropathy; Long non-coding RNAs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Biomarkers / blood
  • Case-Control Studies
  • Down-Regulation / genetics
  • Exosomes / genetics*
  • Female
  • Glomerulonephritis, IGA / blood
  • Glomerulonephritis, IGA / genetics*
  • High-Throughput Nucleotide Sequencing / methods
  • Humans
  • Immunoglobulin A / genetics
  • Male
  • RNA, Long Noncoding / genetics*
  • Receptors, IgG / genetics

Substances

  • Biomarkers
  • Immunoglobulin A
  • RNA, Long Noncoding
  • Receptors, IgG